Searched for
GLOBAL HEALTH TARGET PRICE
US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- NFO Alert: Zerodha Fund House launches 2 target-date Life Cycle fundsZerodha Fund House has launched India’s first target-date Life Cycle Fund series, offering two schemes: 2036 and 2041 maturities. The NFO i...
- Global Markets: Central banks stay vigilant despite oil price relief after US-Iran truceGlobal central banks remain cautious despite easing oil prices following the US-Iran truce. While lower energy costs ease inflation fears, ...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- Stock Radar: Trent broke out from an inverted head & shoulder pattern; time to buy?Trent Ltd stock has broken out of a bullish reversal pattern. Experts recommend buying the stock for a target of Rs 3,500 in the next one t...
- HPV vaccination drive reaches 50 lakh girls in three monthsIndia's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...
- E-Ambulances will get up to 35% PM E-DRIVE subsidyThe government will subsidise electric ambulances. This support is up to 35% of the ex-factory price. Rs 500 crore is allocated for 3,811 e...
- Fuel prices in India won't fall immediately despite global crude slump, MoS Suresh Gopi reveals whyUnion Minister Suresh Gopi explained that immediate fuel price reductions aren't possible despite global crude cost drops due to transit ti...
- Insurers face margin pressure amid rising competition, costs; rural protection gap persists: ReportIndian insurers are feeling the pinch from fierce price wars and increasing operational expenses. To thrive, they must manage capital wisel...
- Target Corp leases 8.3 lakh sq ft office space in Bengaluru for 10 yearsUS retail giant Target Corporation secures a significant office space in Bengaluru. The company will occupy over 8.3 lakh square feet at Em...
- EU chases tech independence but gaps remainEurope wants more homegrown tech to cut its dependencies on the United States and China, but the EU warned Wednesday the bloc has more work...
- Stock Radar: MRPL bounces back after forming double bottom formation; stock still down 25% from highs – should you buy?Mangalore Refinery and Petrochemicals Ltd stock is showing positive signals. A double bottom formation on daily charts indicates a potentia...
- India makes gains in child, maternal health but nutrition challenges persist: SBI reportIndia's latest health survey reveals significant improvements in maternal care and child vaccination rates. Stunting among children has see...
- India's rice stocks climb to record high; wheat inventories at five-year peakIndia's government warehouses hold record rice stocks, up 15% from last year. Wheat inventories are at a five-year peak. These abundant res...
- Nomura raises Adani Ports share price target by 12%. Here are 3 major reasons whyNomura has raised its target price on Adani Ports and Special Economic Zone to Rs 2,080 from Rs 1,850, while retaining its Buy rating. The ...
- India’s fertiliser subsidy model is broken; direct income support is the only way forward: Ashok GulatiIndia’s fertiliser subsidy regime is facing scrutiny; rising global fertiliser and energy prices and rising fiscal pressures expose its ine...
- Buy, Sell or Hold: RIL remains Morgan Stanley's top pick; remains underweight on Oil IndiaBrokerages remain selective on India's energy sector, favouring companies with strong growth drivers and attractive valuations. Morgan Stan...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
Load More
